2012 to 2017 Isothermal Nucleic Acid Amplification Technologies Market Research Report on Molecular diagnostics, infectious disease testing, blood screening, cancer research, rapid testing

Document Sample
2012 to 2017 Isothermal Nucleic Acid Amplification Technologies Market Research Report on Molecular diagnostics, infectious disease testing, blood screening, cancer research, rapid testing Powered By Docstoc
					RnR Market Research Offers “Isothermal Nucleic Acid Amplification Technologies Market
(2012-2017) (Molecular diagnostics, infectious disease testing, blood screening, cancer
research, rapid testing)“Report at US$ 4650 (Single User License). The report got published
in Oct 2012.




The research analysis titled “Isothermal Nucleic Acid Amplification Technologies (INAAT)” discloses the
promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory
research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test
that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple
to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment
free and Deliverable to the end user (ASSURED). Nucleic acid amplification tests targeting pathogen
markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of
affordability, rapidity, and being equipment free. However, INAAT has recently attracted the scientific
community due to their operation in single temperature and distinct features by meeting the ASSURED
guidelines. With fine-tunings in the amplification methodology, a variety of INAAT types are discovered each
being independent, driving the diagnostic platform towards Point-Of-Care (POC) testing at low resource
settings.

This research report provides in-depth details about technology evolution, and innovation trends across the
industry, technology investment potential and competitive market landscape. The analyses ensuing out of
this research service may provide, useful insights for end users, while prioritizing the appropriate choice of
modality for nucleic acid testing in research and diagnostics.

Get your copy of this report @ http://www.rnrmarketresearch.com/isothermal-nucleic-acid-
amplification-technologies-market-2012-2017-molecular-diagnostics-infectious-disease-
testing-blood-screening-cancer-research-rapid-testing-market-report.html

In brief, this research report provides:
     A detailed description of the global technology developments and evolving trends, in the INAAT field
         with key prominence on product innovations by industries, and collaborative efforts by the academic
         research institutions.
     A comprehensive picture of the different types of INAAT platforms available with an exhaustive
         overview of their application prospective.
     An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of
         INAAT during the period from 2012 to 2017.
     Market size – Global market forecast for the next 5 years, including demand side analysis and
         strategic recommendations for technology/product developers.
     Prioritized INNAT types through the Analytical Hierarchy Process (AHP) based on competitive
         benchmarking, technology management strategies and technology roadmap.
     Competitive landscape based on the analysis of key patents and research publications that gives an
         insight into prominent activities and global participants.

Main Driver:
       Global prevalence of infections and cancer: An effective diagnosis of diseases is the first step
        towards personalized medicine. Over 1 billion people are afflicted owing to infectious diseases and
        cancer especially in the tropical/developing countries where access to diagnostics labs are limited.

Main Restraint:
    Conservative mindset for INAAT usage: Most of the end users perceive PCR to be more reliable
       standard for detection. This is true for some of the developing and developed countries. Owing to the
       lack of knowledge or awareness about the advances in the latest technological developments in
       INAAT. This is perceived as a restraint for INAAT market

Main Challenge:
    Market penetration of INAAT: Penetrating new markets in China, India and Middle could be
       competitive for INAAT based players due to high competition from players who are already suppliers
       of PCR based products. However this could be a big advantage for PCR diagnostic product
       manufacturers, since they have capability to adopt these new technologies.

Table of Contents

1 Introduction
1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Sources
2 Executive Summary
3 Isothermal Nucleic Acid Amplification Technologies (INAAT) – Technology Landscape Analysis
3.1 Technology Overview
3.2 INAAT Vs Conventional Methods – Competitive Advantages
3.3 Technology Value Chain Analysis
3.4 Comparative Analysis Of INAAT Types
3.5 Applications
3.5.1 INAAT - Molecular Diagnostics
3.5.1.1. Infectious Disease Diagnostics
3.5.1.2. Blood Screening
3.5.2 INAAT - Research Applications
3.5.2.1 Laboratory Research
3.5.2.2 Cancer Research
3.6 Product/Technology Innovations - Applications
4 Technology Investment Potential
4.1 Investment Climate Assessment
4.1.1 Public Funding Bodies
4.1.2 Philanthropic Bodies
4.1.3 Private Investors & Venture Capital Firms
4.1.4 Insights On Current And Future Tech-Investment Trends
4.1.5 Some Of The Funds And Investments On INAAT
4.2 Investor Network
4.2.1 Investment Opportunities
4.2.1.1 Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
4.2.2.2 Analysis Of Potential Application Areas For Technology Investment Using OSE Grid
5 INAAT - Market Landscape Analysis
5.1 Market Segmentation
5.2 INAAT Market Share In Molecular Diagnostics (MDX)
5.3 Global Market Forecast
5.3.1 By Geography
5.3.2 By Applications
5.4 Market Dynamics
5.4.1 Drivers
5.4.2 Restraints
5.4.3 Challenges
5.4.4 Current And Emerging Opportunities
5.5 Demand Side Analysis
6 INAAT – Technology Adoption Potential And Development By Geography
6.1 Technology Adoption & Development – Key Findings
6.2 North America
6.3 Europe
6.4 ASIA
6.5 Rest Of The World
6.6 Regions With High Technology Adoption
7 Competitive Landscape
7.1 Mergers & Acquisitions (2007-2012)
7.2 Partnerships & Collaborations (2007-2012)
7.3 New Product Development Initiatives – 2012
7.3.1 List of NEW approved INAAT products – 2012
7.3.2 INAAT products – IN Pipeline
7.3.3 Research Innovations
8 Patent Analysis And Research Trend (Publications) 2007-2012
8.1 Patent Landscape Analysis (2007-2012)
8.2 Research Landscape (2007-2012)
9 TECHNOLOGY ANALYSIS (USING AHP) AND ROAD MAPPING
10 Analyst Insights And Recommendations
10.1 Strategic Recommendations For Technology And Business Management
10.2 Key Invitations & Opportunities
11 Company Profiles
11.1 BECTON, DICKINSON AND COMPANY (BD)
11.2 BIOHELIX
11.3 BIOMERIEUX
11.4 EIKEN CHEMICAL CO., LTD.
11.5 HOLOGIC GEN-PROBE
11.6 LUCIGEN
11.7 MERIDIAN BIOSCIENCE INC
11.8 NEW ENGLAND BIOLABS
11.9 NOVARTIS DIAGNOSTICS
11.1 NUGEN
11.11 QIAGEN
11.12 TWISTDX
11.13 USTAR BIOTECHNOLOGIES (HANGZHOU) LTD.
12 Appendix
13 Glossary

For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441
Website: http://www.rnrmarketresearch.com/

				
DOCUMENT INFO
Description: RnR Market Research analysis titled “Isothermal Nucleic Acid Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED).